Immuno-Oncology Summit (Seaport WTC @ Boston)
August 27, 2018 - August 31, 2018
Location:

Seaport WTC - Boston, MA

Details:

ACD will be at booth #113 at the Immuno-oncology Summit in Boston, MA. 

Scheduled ACD presentation:

BIOMARKERS TO PREDICT RESPONSE TO IMMUNOTHERAPY Session

Tuesday, August 28 (@ Waterfront Room 1) , 3:00 pm - 3:30 pm

Expanding CDx Strategy Options with RNAscope®, A Clinically-Validated, Quantitative in situ RNA Biomarker Platform 

Presented by: Chris Bunker, PhD, Vice President, Business Development, Advanced Cell Diagnostics

RNAscope is a clinically validated in situ hybridization assay that enables multiplexed tissue expression analysis in routine clinical biopsy tissues. RNAscope is the most sensitive and specific platform for tissue-based expression analysis. It is enabling faster, robust and wide dynamic range tissue-based biomarker expression analysis for accurate correlation to treatment outcome and selection of responsive patient for clinical trial enrollment and CDx.

Come see the talk from ACD

X
Contact Us

Complete one of the two forms below and we will get back to you.

Advanced Cell Diagnostics

Our new headquarters office starting May 2016:

7707 Gateway Blvd.  
Newark, CA 94560
Toll Free: 1 (877) 576-3636
Phone: (510) 576-8800
Fax: (510) 576-8798

 

Bio-Techne

19 Barton Lane  
Abingdon Science Park
Abingdon
OX14 3NB
United Kingdom
Phone 2: +44 1235 529449
Fax: +44 1235 533420

 

 

Advanced Cell Diagnostics China

Building 15, No. 26 Xihuan South Road
Beijing Economic-Technological Development Area
Beijing, China, Zip code: 100176

400-966-1796
info_china.ACD@bio-techne.com
For general information: Leon.Li@bio-techne.com
Web: www.acdbio.com/cn

For general information: Info.ACD@bio-techne.com
For place an order: order.ACD@bio-techne.com
For product support: support.ACD@bio-techne.com
For career opportunities: hr.ACD@bio-techne.com